These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6160902)

  • 1. Further experience in treating patients with hepatocellular carcinoma in Uganda.
    Olweny CL; Katongole-Mbidde E; Bahendeka S; Otim D; Mugerwa J; Kyalwazi SK
    Cancer; 1980 Dec; 46(12):2717-22. PubMed ID: 6160902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraarterial adriamycin and lipiodol for inoperable hepatocellular carcinoma: a comparison with intravenous adriamycin.
    Kalayci C; Johnson PJ; Raby N; Metivier EM; Williams R
    J Hepatol; 1990 Nov; 11(3):349-53. PubMed ID: 1705275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraaterial hepatic infusion and intravenous adriamycin for treatment of hepatocellular carcinoma: a clinical and pharmacology report.
    Bern MM; McDermott W; Cady B; Oberfield RA; Trey C; Clouse ME; Tullis JL; Parker LM
    Cancer; 1978 Aug; 42(2):399-405. PubMed ID: 209882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemotherapy for advanced hepatocellular carcinoma. Adriamycin versus quadruple chemotherapy.
    Choi TK; Lee NW; Wong J
    Cancer; 1984 Feb; 53(3):401-5. PubMed ID: 6198058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adriamycin treatment for hepatocellular carcinoma. Experience with 109 patients.
    Sciarrino E; Simonetti RG; Le Moli S; Pagliaro L
    Cancer; 1985 Dec; 56(12):2751-5. PubMed ID: 2413981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hepatocellular carcinoma with adriamycin. Preliminary communication.
    Olweny CL; Toya T; Katongole-Mbidde E; Mugerwa J; Kyalwazi SK; Cohen H
    Cancer; 1975 Oct; 36(4):1250-7. PubMed ID: 169983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of vinyl chloride-associated hepatic angiosarcoma.
    Dannaher CL; Tamburro CH; Yam LT
    Cancer; 1981 Feb; 47(3):466-9. PubMed ID: 6261909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Intraarterial Adriamycin for patients with hepatocellular carcinoma and metastatic liver carcinoma].
    Ueoka H; Kuroda S; Ohnoshi T; Kimura I; Numoto A; Hino I; Takahashi M; Tsuji M
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2579-84. PubMed ID: 6095763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase II study of adriamycin (NSC 123127) in patients with hepatocellular carcinoma from Zambia and the United States.
    Vogel CL; Bayley AC; Brooker RJ; Anthony PP; Ziegler JL
    Cancer; 1977 May; 39(5):1923-9. PubMed ID: 66974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adriamycin in the treatment of resectible and irresectible primary hepatocellular carcinoma.
    Oon CJ; Chua EJ; Foong WC; Tan LK; Yo SL; Chang CH; Ho ST; Seah CS
    Ann Acad Med Singap; 1980 Apr; 9(2):256-9. PubMed ID: 6252816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunochemotherapy with recombinant interleukin-2 and adriamycin in primary hepatocellular carcinoma.
    Chien CH; Hsieh KH; Yang PM
    Asian Pac J Allergy Immunol; 1991 Dec; 9(2):75-81. PubMed ID: 1666952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic arterial chemotherapy and occlusion for palliation of primary hepatocellular and unknown primary neoplasms in the liver.
    Patt YZ; Chuang VP; Wallace S; Benjamin RS; Fuqua R; Mavligit GM
    Cancer; 1983 Apr; 51(8):1359-63. PubMed ID: 6186357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemotherapy of hepatocellular carcinoma--with special reference to one-shot intra-arterial infusion of a high dose of adriamycin].
    Hirose H; Aoyama M; Oshima K; Udo K; Kobayashi S; Adachi N; Nonaka T; Yamada T
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2216-21. PubMed ID: 6307182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adriamycin and methyl-CCNU combination therapy in hepatocellular carcinoma: clinical and pharmacokinetic aspects.
    Chlebowski RT; Chan KK; Tong MJ; Weiner JM; Ryden VM; Bateman JR
    Cancer; 1981 Sep; 48(5):1088-95. PubMed ID: 6268277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of remission in hepatocellular carcinoma with doxorubicin.
    Johnson PJ; Williams R; Thomas H; Sherlock S; Murray-Lyon IM
    Lancet; 1978 May; 1(8072):1006-9. PubMed ID: 76932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic artery infusion chemotherapy with cisplatin and adriamycin in combination with angiotensin-II in the treatment of malignant liver tumors].
    Morita S; Matsumoto S; Odani R
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):689-95. PubMed ID: 2451473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcatheter oily chemoembolization with high doses of adriamycin in the treatment of large hepatocellular carcinoma (10 cm or more in diameter).
    Nakamura H; Hashimoto T; Inoue Y; Inoue K; Akaji H; Sawada S
    Radiat Med; 1990; 8(5):188-90. PubMed ID: 1963695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival results among patients with alpha-fetoprotein-positive, unresectable hepatocellular carcinoma: analysis of three sequential treatments of the RTOG and Johns Hopkins Oncology Center.
    Abrams RA; Pajak TF; Haulk TL; Flam M; Asbell SO
    Cancer J Sci Am; 1998; 4(3):178-84. PubMed ID: 9612600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hepatocellular carcinoma by intraarterial injection of adriamycin/mitomycin C oil suspension (ADMOS) alone or combined with cis-diaminodichloroplatinum (CDDP).
    Inoue H; Miyazono N; Hori A; Miyake S; Satake M; Kanetsuki I; Nishida H; Ikeda K; Nakajo M
    Acta Radiol; 1993 Jul; 34(4):388-91. PubMed ID: 8391290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adriamycin and cisplatin for hepatoblastoma.
    Quinn JJ; Altman AJ; Robinson HT; Cooke RW; Hight DW; Foster JH
    Cancer; 1985 Oct; 56(8):1926-9. PubMed ID: 2411381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.